Wietske I. Luining

Amsterdam University Medical Centers

Papers

1

Total Citations

10

H-Index

1

About

Dr. Wietske I. Luining is a leading researcher in the field of urologic oncology, with a primary focus on improving the staging and management of prostate cancer through advanced imaging techniques. Her most impactful work centers on the clinical utility of prostate-specific membrane antigen (PSMA) PET/CT, demonstrating its superiority over conventional imaging for pre-surgical staging. In her highly cited 2024 study, Dr. Luining and her team showed that patients undergoing PSMA PET/CT before radical prostatectomy and extended pelvic lymph node dissection achieved significantly better early oncological outcomes, including lower rates of biochemical recurrence. This landmark paper, already accruing 10 citations within its first year, has helped shift clinical practice toward more precise, imaging-guided treatment planning. Dr. Luining’s contributions are pivotal in bridging the gap between advanced molecular imaging and surgical decision-making, ultimately aiming to reduce unnecessary treatments and improve patient survival. Her work continues to influence guidelines and inspire further research into personalized, image-driven strategies for prostate cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node Dissection
10 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Amsterdam University Medical Centers

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago